Sheba Medical Center is a world leader in using new immunotherapy treatments to treat desperately ill children and adults who suffering from a variety of cancers. CAR-T, a treatment where a patient’s immune cells are re-engineered to attack only cancer cells, is showing tremendous promise. With a success rate over 70%, CAR-T is now being used to treat children and adults with leukemia and lymphoma.
The research in Dr. Talia Golan’s translational research lab focuses on improving the standard of care options for pancreatic cancer patients by finding targeted treatments tailored for each patient. After deciphering the mechanism of resistance to specific treatments, the researchers screen various drug combinations to find ones with potential to work more effectively. These targeted treatments are based on the patient’s own genetic background and state-of-the-art early detection methodology.
Prof. Michal Beeri, who heads the Sagol Neuroscience Research Center at Sheba, is offering real hope in preventing the onset of dementia and Alzheimer’s. Her clinical trials have shown that increased physical and cognitive activities can actually slow down the progression of this terrible disease. Beeri’s studies have demonstrated that people who engage in specific physical, social and cognitive activities on a regular basis stand an excellent chance of postponing the onset of the illness.
As Israel’s only national medical simulation center, MSR provides training that enables healthcare professionals to effectively practice challenging procedures and improve their communications skills in clinical settings. Some medical simulation technologies include computer-driven, full-body mannequins that allow doctors to test their skills with challenging and high-risk clinical conditions and procedures, role-playing actors who simulate difficult patients and advanced virtual reality that improves the complex manual and technical skills of medical personnel.